SureTrader SureTrader
Home > Boards > US Listed > Biotechs > Compugen (CGEN)

Yep its posted:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DAD2 Member Profile
 
Followed By 65
Posts 5,108
Boards Moderated 0
Alias Born 03/11/09
160x600 placeholder
Compugen Discloses Development of Enhanced LINKS Platform Utilized for the Discovery of Myeloid Targets for Cancer Immunother... "PR Newswire (US)" - 8/30/2016 7:00:00 AM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 8/25/2016 10:13:31 AM
Securities Registration (foreign Private Issuer) (f-3) "Edgar (US Regulatory)" - 8/9/2016 6:32:18 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/9/2016 6:12:43 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/2/2016 7:02:10 AM
Compugen Ltd. Reports 2nd Quarter 2016 Financial Results "PR Newswire (US)" - 8/2/2016 7:01:00 AM
Compugen Second Quarter 2016 Conference Call Scheduled for Tuesday, August 2, 2016 at 10:00 AM ET "PR Newswire (US)" - 7/21/2016 7:00:00 AM
Compugen Discloses Lead Therapeutic Candidate for CGEN-15029 Immuno-Oncology Program "PR Newswire (US)" - 6/22/2016 7:09:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 6/22/2016 7:02:52 AM
Compugen to Present at JMP Securities Life Sciences Conference in New York "PR Newswire (US)" - 6/15/2016 7:00:00 AM
Compugen to Present at the Jefferies Global Healthcare Conference in New York "PR Newswire (US)" - 5/23/2016 7:00:00 AM
Compugen to Present at the Oppenheimer Annual Israeli Conference in Tel Aviv "PR Newswire (US)" - 5/16/2016 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/10/2016 7:05:21 AM
Compugen Ltd. Reports First Quarter 2016 Financial Results "PR Newswire (US)" - 5/10/2016 7:01:00 AM
Steven Holtzman Joins Compugen as Strategic Business Advisor "PR Newswire (US)" - 5/10/2016 6:45:00 AM
Compugen First Quarter 2016 Conference Call and Webcast Scheduled for Tuesday, May 10, 2016 at 10:00 AM ET "PR Newswire (US)" - 4/27/2016 7:15:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 4/20/2016 7:13:20 AM
Compugen Achieves Preclinical Milestone in Cancer Immunotherapy Collaboration With Bayer "PR Newswire (US)" - 4/18/2016 7:14:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 4/18/2016 7:08:15 AM
Dr. Elliott Sigal Joins Compugen Ltd. as Strategic Advisor and Prof. Drew Pardoll Appointed Director at Compugen USA, Inc. "PR Newswire (US)" - 4/6/2016 7:00:00 AM
Compugen to Present at the Jefferies Immuno-Oncology Summit in Boston "PR Newswire (US)" - 3/28/2016 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 3/8/2016 7:01:58 AM
Compugen Presents Results for CGEN-15029 Immuno-Oncology Therapeutic Program "PR Newswire (US)" - 2/29/2016 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 2/9/2016 7:11:29 AM
Compugen Ltd. Reports Fourth Quarter and Calendar 2015 Results "PR Newswire (US)" - 2/9/2016 7:09:00 AM
DAD2   Tuesday, 02/07/12 07:23:17 AM
Re: Penny Roger$ post# 111
Post # of 150 
Yep its posted:

Zero revenues in the 4th quarter and the net loss for the 4th quarter was $4.4 million.

Might pull back slightly imo.

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist